study-cbd-mitigates-stress-in-those-clinically-at-high-risk-of-psychosis 
The Joint Blog
JANUARY 31, 2020
Cannabidiol (CBD) use is associated with reduced stress levels in those diagnosed with a clinically high risk (CHR) of psychosis. Half of the CHR participants were on 600 mg/day of CBD (CHR-CBD) and half were on placebo (CHR-P) for 1 week.
Cannabis Law Report
SEPTEMBER 23, 2019
Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health.
StrainConnect
FEBRUARY 8, 2019
Your guide to hemp, cannabis, and all things CBD. If you’re here, it means you may be interested in CBD for yourself, a friend or a loved one, or perhaps you’re an industry professional conducting research. Consider us your home for CBD, hemp and cannabis research, education, and personalized product recommendations.
Expert insights. Personalized for you.
49 
Let's personalize your content